TMDX
insider transactionsTransMedics Group, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-17.4K
25.6K buy · 43.0K sell
Net value · 365d
-$2.4M
$3.0M in · $5.4M out
Sentiment · 365d
Net selling
36% buying · 64% selling
Open-market trades · 365d
17
25.6K buy · 43.0K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
Transactions · 365d
-
Sell·S
Director
$722.4K
9.6K sh · $75.06
Own -37%
-
Sell·S
Chief Financial Officer
$1.1M
7.6K sh · $146.81 avg · 3 lots
Own -34%
-
Sell·S
Director
$178.5K
1.2K sh · $149.62
Own -29%
-
Sell·S
Director
$524.3K
3.6K sh · $146.82
Own -23%
-
Sell·S
See remarks
$120.2K
864 sh · $139.12
Own -6%
-
Sell·S
See remarks
$412.6K
3.0K sh · $139.12
Own -9%
-
Sell·S
Chief Financial Officer
$128.5K
920 sh · $139.62
Own -6%
-
Sell·S
Director
$693.2K
5.0K sh · $138.64
Own -29%
-
Sell·S
See remarks
$435.7K
3.0K sh · $145.22
Own -18%
-
Sell·S
Director · 10b5-1
$540.3K
4.1K sh · $130.45
Own -59%
-
Sell·S
Director · 10b5-1
$520.0K
4.1K sh · $125.51
Own -59%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Gunderson Thomas James | Sell S | 9.6K | $722.4K |
| Mar 4, 2026 | Hernandez Gerardo KEY | Sell S | 7.6K3 lots | $1.1M |
| Mar 4, 2026 | Lovell Stephanie | Sell S | 1.2K | $178.5K |
| Mar 4, 2026 | Weill David | Sell S | 3.6K | $524.3K |
| Mar 2, 2026 | Ranganath Anil P. | Sell S | 864 | $120.2K |
| Mar 2, 2026 | Corcoran Nicholas | Sell S | 3.0K | $412.6K |
| Dec 4, 2025 | Hernandez Gerardo KEY | Sell S | 920 | $128.5K |
| Dec 3, 2025 | Weill David | Sell S | 5.0K | $693.2K |
| Nov 25, 2025 | Ranganath Anil P. | Sell S | 3.0K | $435.7K |
| Oct 29, 2025 | Basile Edward M 10b5-1 | Sell S | 4.1K | $540.3K |
| Aug 4, 2025 | Basile Edward M 10b5-1 | Sell S | 4.1K | $520.0K |
Buy Sell Non-market (grant · exercise · gift)
About TMDX insider trading
This page tracks insider transactions for TransMedics Group, Inc. (TMDX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.